Content area
Full Text
MORE details have emerged on the merger of Omicron Investment Management and Aurelius Capital.
The two companies will continue as separate legal entities, managed by the same people, Dr Hans-Michael Schania and Michael Dirnegger, and will combine cost bases, such as the IT systems.
Calyon and Aurelius hope the merger will benefit both businesses.
"We wanted to combine with an organisation we could do business with in the future, one that could increase the spectrum of opportunities for Omicron," said Laurent...